Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Price:
31.96
USD
-1.6%
Market Closed
Market Cap:
$1.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Agios Pharmaceuticals Inc
NASDAQ:AGIO
|
US |
|
Torq Resources Inc
F:S8QN
|
CA |
|
J
|
Japan Tobacco Inc
XMUN:JAT
|
JP |
|
Gold Fields Ltd
F:EDG
|
ZA |
|
Barratt Redrow PLC
F:3BAA
|
UK |
|
C
|
CTT - Correios de Portugal SA
ELI:CTT
|
PT |
|
T
|
Thunderstruck Resources Ltd
OTC:THURF
|
CA |
|
S
|
Sunstone Metals Ltd
F:AL9
|
AU |
|
CK Hutchison Holdings Ltd
F:2CK
|
HK |
|
Evogene Ltd
NASDAQ:EVGN
|
IL |
|
Safestore Holdings PLC
LSE:SAFE
|
UK |
Wall St Price Targets
AGIO Price Forecast
Based on 10 analysts
Based on 10 analysts
+60% Upside
from
$31.96
today
Agios Pharmaceuticals Inc (AGIO)’s 12-month stock price forecast through October 2027 has a consensus target of $51, implying 60% upside. The forecast is based on price targets from 10 Wall Street analysts.
AGIO Analyst Rating
Based on 9 analysts
Based on 9 analysts
Analysts rate AGIO Buy, with 6 of 9 recommending Buy or Strong buy.
Agios Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AGIO's stock price target?
Price Target
51
USD
51
USD
According to Wall Street analysts, the average 1-year price target for AGIO is 51 USD with a low forecast of 32.32 USD and a high forecast of 76.65 USD.
What is the Revenue forecast for Agios Pharmaceuticals Inc?
Projected CAGR
44%
44%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 44%.
What is the Gross Profit forecast for Agios Pharmaceuticals Inc?
Projected CAGR
67%
67%
The compound annual growth rate for Gross Profit over the next 5 years is 67%.